NCT00002340View on ClinicalTrials.gov

A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX

PHASE3CompletedINTERVENTIONAL

Enrollment

615

Participants

Timeline

Start Date

Not specified

Conditions

Pneumonia, Pneumocystis CariniiHIV Infections

Interventions

DRUG

Atovaquone

DRUG

Pentamidine isethionate

Trial Locations (5)

10011

Saint Vincent's Hosp and Med Ctr, New York

23666

Hampton Roads Med Specialists, Hampton

32751

Goodgame Med Group, Maitland

33609

Bay Area AIDS Consortium, Tampa

452670405

Holmes Hosp, Cincinnati

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Glaxo Wellcome

INDUSTRY

NCT00002340 - A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX | Biotech Hunter | Biotech Hunter